Stocks making the biggest moves premarket: Johnson & Johnson, FedEx, Zions and more
FedEx’s shares gained more than 2% before the bell after announcing a dividend hike and a corporate reorganization. Original source: https://www.cnbc.com/2023/04/05/stocks-making-the-biggest-moves-premarket-jnj-fdx-zion.html
Read More »Stocks making the biggest moves premarket: Johnson & Johnson, Goldman Sachs, fuboTV and more
The stocks posting the largest moves before the bell include Amazon, Hasbro, Nordstrom and more. Original source: https://www.cnbc.com/2022/10/18/stocks-making-the-biggest-moves-premarket-johnson-johnson-goldman-sachs-fubotv-and-more.html
Read More »Johnson & Johnson – Turnaround-Chance bei der Aktie des Health-Care Giganten!
Bottom-Fishing Trading-Strategie Symbol: JNJ ISIN: US4781601046 Rückblick: Zum Portfolio des Health-Care Unternehmens gehören sowohl verschreibungspflichtige wie auch frei erhältliche Präparate. Die umfangreiche Produktpalette wird dabei unter bekannten Marken wie Johnson’s,…
Read More »Market Update – November 15 – Market eyes Geopolitics & Stimulus
USD (USDIndex 02) spiked to 95.25 (new 16-mth high) on Friday. The consumer sentiment data (10-yr low)and JOLTS provided mixed views, with confidence plunging, 1-year inflation rising, and a slip in job openings, but a…
Read More »Why Can’t I Short Some Penny Stocks?
Many traders check the daily gainers & losers list in their screener and find an overhyped penny stock that could be a favorable short-selling opportunity. But when they go…
Read More »Tesla Added to S&P 500: What’s Next?
It was recently announced that Tesla would be added to the S&P 500 index before the open on December 21, 2020, ending years of speculation by Tesla fans and critics…
Read More »Linear vs Logarithmic Chart Scaling Explained
The style of chart scaling you use on your price charts is one of those seemingly unimportant details that can dramatically affect how you perceive market action. Linear vs…
Read More »J&J Coronavirus vaccine candidate – induced immune response, showed acceptable safety profile
Johnson & Johnson’s experimental Covid-19 vaccine phase 1/2 trial findings have provided some encouragement. Reports the Wall Street Journal: Now for some caveats. These are from a small early-stage trial….
Read More »